Updated:
FCA Venture Partners
FCA Venture Partners is a healthcare-focused investment firm funding healthcare forward. The firm has 15+ years investing in healthcare, 60+ healthcare...
FCA Venture Partners
FCA Venture Partners is a healthcare-focused investment firm funding healthcare forward. The firm has 15+ years investing in healthcare, 60+ healthcare investments, and $335 M capital raised, along with 12 strategic partners. FCA has developed deep domain expertise and a valuable network in four sectors of the healthcare market: Providers, Payers, Pharma, and Innovative Care Delivery.
General information
Firm type
Venture Capital
Year founded
1996
Location
Region
North America
Country
United States
City
Nashville
Corporate office
Nashville, TN, United States
Principals
Matt King
Managing Partner
Andrew Bouldin
Managing Partner
Todd Johnson
Partner
John Burch
Partner
Tom Hearn
Partner
Whitney Kalb
Partner & General Counsel
George Curran
Principal
Andy Lutz
Principal
Will Hawkins
Principal
John Orr
Vice President
Tucker Deaton
Director of Finance
Sector focus
Frequently asked questions
How does FCA Venture Partners source proprietary deal flow?
FCA draws its pipeline partly from its limited-partner base of healthcare organizations, provider groups, payers, and pharma executives. These strategic partners often surface companies addressing operational problems they experience firsthand. The firm also leans on its portfolio-CEO network and the concentration of healthcare operators in the Nashville market for referrals.
Does FCA participate in fund commitments or only direct deals?
FCA's strategy centers on direct investments into operating healthcare companies. The firm's website describes writing $2 million to $8 million checks into Seed and Series A/B rounds, with no mention of fund-of-fund commitments or investing as a limited partner in other venture funds.
Which sectors does FCA explicitly avoid?
FCA invests only in healthcare, organized across four internal themes: Providers, Payers, Pharma, and Innovative Care Delivery. It does not invest in other verticals such as enterprise software, fintech, or climate — making its negative screen anything outside healthcare technology and services.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: